Nobuo Murakami

2.9k total citations
93 papers, 2.3k citations indexed

About

Nobuo Murakami is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Nobuo Murakami has authored 93 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Nobuo Murakami's work include Thyroid Cancer Diagnosis and Treatment (30 papers), Thyroid Disorders and Treatments (18 papers) and Thyroid and Parathyroid Surgery (10 papers). Nobuo Murakami is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (30 papers), Thyroid Disorders and Treatments (18 papers) and Thyroid and Parathyroid Surgery (10 papers). Nobuo Murakami collaborates with scholars based in Japan and United States. Nobuo Murakami's co-authors include Shiro Noguchi, Hitoshi Kawamoto, Akito Noguchi, Hiroto Yamashita, Shin Watanabe, Masakatsu Toda, Hiroyuki Yamashita, Iwao Nakayama, Hisataka Moriwaki and Shigeo Yokoyama and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cancer.

In The Last Decade

Nobuo Murakami

91 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuo Murakami Japan 23 1.4k 1.0k 360 292 229 93 2.3k
Masoud Solaymani–Dodaran Iran 26 211 0.2× 1.1k 1.0× 465 1.3× 180 0.6× 123 0.5× 78 2.5k
Gerald A. Coles United Kingdom 35 127 0.1× 959 0.9× 183 0.5× 95 0.3× 114 0.5× 107 3.6k
Matthias Turina Switzerland 21 344 0.3× 855 0.8× 326 0.9× 273 0.9× 52 0.2× 90 1.7k
Mariana Murea United States 25 222 0.2× 240 0.2× 177 0.5× 60 0.2× 113 0.5× 71 2.1k
J. Armstrong United Kingdom 23 147 0.1× 238 0.2× 560 1.6× 225 0.8× 45 0.2× 51 2.0k
Nikhil Gupta India 24 227 0.2× 900 0.9× 225 0.6× 359 1.2× 154 0.7× 237 2.2k
Neal R. Barshes United States 35 659 0.5× 2.0k 1.9× 437 1.2× 317 1.1× 91 0.4× 148 3.3k
Benaya Rozen‐Zvi Israel 20 150 0.1× 287 0.3× 198 0.6× 81 0.3× 53 0.2× 81 2.1k
Hanjing Zhuo United States 29 179 0.1× 558 0.5× 897 2.5× 134 0.5× 38 0.2× 60 3.8k
Ira Klimberg United States 22 181 0.1× 584 0.6× 712 2.0× 134 0.5× 39 0.2× 49 2.0k

Countries citing papers authored by Nobuo Murakami

Since Specialization
Citations

This map shows the geographic impact of Nobuo Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Murakami more than expected).

Fields of papers citing papers by Nobuo Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Murakami. The network helps show where Nobuo Murakami may publish in the future.

Co-authorship network of co-authors of Nobuo Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Murakami. A scholar is included among the top collaborators of Nobuo Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Murakami. Nobuo Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawamura, Kumiko, Kouji Kimura, Jun‐ichi Wachino, et al.. (2018). Prevalence of CTX-M-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli B2-O25-ST131 H30 R Among Residents in Nonacute Care Facilities in Japan. Microbial Drug Resistance. 24(10). 1513–1520. 15 indexed citations
2.
Kumada, Keisuke, Nobuo Murakami, Hideshi Okada, et al.. (2016). Rare central venous catheter malposition – an ultrasound-guided approach would be helpful: a case report. Journal of Medical Case Reports. 10(1). 248–248. 4 indexed citations
3.
Goto, Naoe, Hisashi Tsurumi, Senji Kasahara, et al.. (2011). Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens. European Journal Of Haematology. 87(3). 217–227. 23 indexed citations
4.
Niwa, Takashi, et al.. (2010). Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics. International Journal of Antimicrobial Agents. 35(5). 507–510. 23 indexed citations
5.
Niwa, Takashi, Akio Suzuki, Senji Kasahara, et al.. (2009). Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy. Clinical Therapeutics. 31(10). 2126–2133. 54 indexed citations
7.
Noguchi, Shiro, Mari Sato, Hiroyuki Yamashita, et al.. (1999). Presymptomatic detection and treatment of Japanese carriers of the multiple endocrine neoplasia type 2A gene. Surgery Today. 29(9). 862–867. 6 indexed citations
8.
Yuma, Masahide, et al.. (1998). . Journal of Environmental Conservation Engineering. 27(4). 289–295.
9.
Uchino, Shinya, Shiro Noguchi, Mari Sato, et al.. (1998). Novel Point Mutations and Allele Loss at the RET Locus in Sporadic Medullary Thyroid Carcinomas. Japanese Journal of Cancer Research. 89(4). 411–418. 35 indexed citations
10.
Noguchi, Shiro, Nobuo Murakami, Hiroto Yamashita, Masakatsu Toda, & Hitoshi Kawamoto. (1998). Papillary Thyroid Carcinoma. Archives of Surgery. 133(3). 276–80. 169 indexed citations
11.
Kashima, Kenji, Shigeo Yokoyama, Shiro Noguchi, et al.. (1998). Chronic Thyroiditis as a Favorable Prognostic Factor in Papillary Thyroid Carcinoma. Thyroid. 8(3). 197–202. 138 indexed citations
12.
Kimura, Kiminori, Junichi Sugihara, Nobuo Murakami, et al.. (1997). Successful treatment of severe intrahepatic cholestasis due to methimazole with bilirubin absorption and plasma exchange.. Kanzo. 38(3). 172–177. 1 indexed citations
13.
Kondo, Akio, Yasuo Koike, Masakatsu Toda, et al.. (1997). Statistical Study of Recurrent Nerve Palsy after Thyroid Cancer Surgery. Koutou (THE LARYNX JAPAN). 9(2). 150–155. 1 indexed citations
15.
Yamashita, Hiroyuki, Shin Watanabe, Shinya Uchino, et al.. (1997). Thyroid cancer associated with adenomatous goiter: An analysis of the incidence and clinical factors. Surgery Today. 27(6). 495–499. 38 indexed citations
16.
Yamashita, Hiroyuki, Shiro Noguchi, Kazuki Tahara, et al.. (1997). Postoperative tetany in patients with Graves' disease: a risk factor analysis. Clinical Endocrinology. 47(1). 71–77. 30 indexed citations
17.
18.
Kato, Tomohiro, et al.. (1990). Studies on abnormal metabolism of norepinephrine in the brain of rats with hepatic failure.. Kanzo. 31(2). 160–171. 2 indexed citations
19.
Shimazaki, Makoto, Junichi Sugihara, Nobuo Murakami, et al.. (1989). Three cases of severe acetaminophen overdose.. Kanzo. 30(10). 1520–1525. 2 indexed citations
20.
Yamashita, Hiroto, Shiro Noguchi, Nobuo Murakami, et al.. (1989). Induction of Peroxidase and Thyroglobulin by TSH in Cultured Thyroid Cells from Patients with Basedow's Disease and Its Inhibition by Actinomycin D. Acta Pathologica Japonica. 39(2). 121–126. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026